Ayurcann Holdings Corp.
AYURF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6 | $8 | $8 | $8 |
| % Growth | -21.4% | 2.5% | 0.7% | – |
| Cost of Goods Sold | $5 | $7 | $5 | $4 |
| Gross Profit | $2 | $2 | $3 | $3 |
| % Margin | 25.3% | 19.4% | 34.1% | 43.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $2 | $2 | $2 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $2 | $2 | $1 | $1 |
| Other Operating Expenses | -$1 | $0 | $0 | $0 |
| Operating Expenses | $2 | $3 | $3 | $3 |
| Operating Income | -$1 | -$2 | -$0 | $0 |
| % Margin | -11.3% | -23.8% | -5.1% | 1% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$3 | -$1 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$2 | -$1 | -$0 |
| % Margin | -13% | -24.7% | -7.4% | -1.6% |
| EPS | -0.004 | -0.01 | -0.003 | -0.001 |
| % Growth | 58.2% | -237.9% | -383.3% | – |
| EPS Diluted | -0.004 | -0.01 | -0.003 | -0.001 |
| Weighted Avg Shares Out | 195 | 195 | 195 | 195 |
| Weighted Avg Shares Out Dil | 195 | 195 | 195 | 195 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$0 | $0 |
| % Margin | -9.3% | -29.3% | -2.7% | 4.2% |